Ochratoxin A exposure biomarkers in the Czech Republic and comparison with foreign countries

Biomarkers

Volumn 17, Issue 7, 2012, Pages 577-589

  Malir, Frantisek ^a   Ostry, Vladimir ^b   Pfohl Leszkowicz, Annie ^c   Roubal, Tomas ^d  

^a UNIVERSITY OF HRADEC KRALOVE   (Czech Republic)

^b NATIONAL INSTITUTE OF PUBLIC HEALTH   (Czech Republic)

^c Ecole Nationale Superieure d'Architecture de Toulouse   (France)

^d National Reference Laboratory for Biomarkers of Mycotoxins   (Czech Republic)

Author keywords

Biomarkers; Exposure; Monitoring; Ochratoxin A; OTA

Indexed keywords

BIOLOGICAL MARKER; OCHRATOXIN;

ALGERIA; ARGENTINA; BIOLOGICAL MONITORING; BLADDER CANCER; BLOOD ANALYSIS; BLOOD SAMPLING; BULGARIA; CANADA; CANCER PATIENT; CARCINOGENICITY; CHILE; CHRONIC KIDNEY FAILURE; COSTA RICA; COTE D'IVOIRE; CROATIA; CZECH REPUBLIC; DENMARK; DNA ADDUCT; DRUG EXPOSURE; EGYPT; FRANCE; GENOTOXICITY; GERMANY; GLOMERULONEPHRITIS; GRAFT RECIPIENT; HALF LIFE TIME; HEMODIALYSIS PATIENT; HOSPITAL PATIENT; HUMAN; HUNGARY; IMMUNOTOXICITY; INTERSTITIAL NEPHRITIS; ITALY; JAPAN; KIDNEY; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; LEBANON; LIVER TOXICITY; MILK; MOROCCO; NEPHROTIC SYNDROME; NEPHROTOXICITY; OUTPATIENT; PAKISTAN; POLAND; REVIEW; SIERRA LEONE; SPAIN; SWEDEN; TERATOGENICITY; TUNISIA; TURKEY (REPUBLIC); URINALYSIS; UROGENITAL TRACT TUMOR; YUGOSLAVIA (PRE-1992);

CARCINOGENS; CZECH REPUBLIC; ENVIRONMENTAL EXPOSURE; FOOD CONTAMINATION; HUMANS; KIDNEY; KIDNEY DISEASES; MILK, HUMAN; OCHRATOXINS; TISSUE DISTRIBUTION;

ANIMALIA;

EID: 84867932312     PISSN: 1354750X     EISSN: 13665804     Source Type: Journal    
DOI: 10.3109/1354750X.2012.692392     Document Type: Review

References (138)

1. Abid S, Hassen W, Achour A, Skhiri H, Maaroufi K, Ellouz F, Creppy E, Bacha H. (2003). Ochratoxin A and human chronic nephropathy in Tunisia: is the situation endemic? Hum Exp Toxicol 22:77-84.
2. Akdemir C, Ulker OC, Basaran A, Ozkaya S, Karakaya A. (2010). Estimation of ochratoxin A in some Turkish populations: An analysis in urine as a simple, sensitive and reliable biomarker. Food Chem Toxicol 48:877-882.
3. Aslam M, Beg AE, Blaszkiewicz M, Degen GH, Golka K. (2005). Ochratoxin A blood concentration in healthy subjects and bladder cancer cases from Pakistan. Mycotoxin Res 21:164-167.
4. Assaf H, Betbeder AM, Creppy EE, Pallardy M, Azouri H. (2004). Ochratoxin A levels in human plasma and foods in Lebanon. Hum Exp Toxicol 23:495-501.
5. Battilani P, Pietri VA, Giorni P, Formenti S, Bertuzzi T, Toscani T, Virgili R, Kozakiewicz Z. (2007). Penicillium populations in dry-cured ham manufacturing plants. J Food Prot 70:975-980.
6. Baudrimont I. (1995). Variation de la nephrotoxicit́de l'ochratoxine A sous l'effet de facteurs méaboliques et nonméaboliques. Ph.D. thesis. Bordeaux, Universit́ II, 1-250.
7. Benford D, Boyle C, Dekant W, Fuchs R, Gaylor DW, Hard G, Mc Gregor DB, Pitt JI, Plestina R, Shepard G, Solfrizzo M, Verger PJP,\ Walker R. (2001). Ochratoxin A. In Safety evaluation of certain mycotoxins in food, prepared by the 56th meeting of the Joint FAO/WHO Expert Committee on Food Additives (JECFA): WHO Food Additives Series 47. World Health Organization, Geneva, 47:281-387.
8. Bendele AM, Carlton WW, Krogh P, Lillehoj EB. (1985). Ochratoxin A carcinogenesis in the (C57BL/6J X C3H)F1 mouse. J Natl Cancer Inst 75:733-742.
9. Biasucci G, Calabrese G, Di Giuseppe R, Carrara G, Colombo F, Mandelli B, Maj M, Bertuzzi T, Pietri A, Rossi F. (2011). The presence of ochratoxin A in cord serum and in human milk and its correspondence with maternal dietary habits. Eur J Nutr 50:211-218.
10. Bogs C, Battilani P, Geisen R. (2006). Development of a molecular detection and differentiation system for ochratoxin A producing Penicillium species and its application to analyse the occurrence of Penicillium nordicum in cured meats. Int J Food Microbiol 107:39-47.
11. Breitholtz-Emanuelsson A, Hult K. (1991a). Enzyme-linked immunosorbent assay for analysis of ochratoxin A in human plasma samples using antibodies raised against a new ochratoxin -protein conjugate. In: Castegnaro M, Plestina R, Dirheimer G, Chernozemsky IN, Bartsch H, ed. Mycotoxins, Endemic Nephropathy and Urinary Tract Tumours IARC Scientific Publications. Lyon, France: IARC, 115:89-92.
12. Breitholtz A, Olsen M, Dahlbäk A, Hult K. (1991b). Plasma ochratoxin A levels in three Swedish populations surveyed using an ion-pair HPLC technique. Food Addit Contam 8:183-192.
13. Breitholtz-Emanuelsson A, Olsen M, Oskarsson A, Palminger I, Hult K. (1993). Ochratoxin A in cow's milk and in human milk with corresponding human blood samples. J AOAC Int 76:842-846.
14. Breitholtz-Emanuelsson A, Minervini F, Hult K, Visconti A. (1994). Ochratoxin A in human serum samples collected in southern Italy from healthy individuals and individuals suffering from different kidney disorders. Nat Toxins 2:366-370.
15. Bunge I, Dirheimer G, Röchenthaler R. (1978). In vivo and in vitro inhibition of protein synthesis in Bacillus stearothermophilus by ochratoxin A. Biochem Biophys Res Commun 83:398-405.
16. Burdaspal PA, Legarda TM. (1998). Datos sobre la presencia de ochratoxina A en plasma humano en Espana. Alimentaria 292:103-109.
17. Castegnaro M, Canadas D, Vrabcheva T, Petkova-Bocharova T, Chernozemsky IN, Pfohl-Leszkowicz A. (2006). Balkan endemic nephropathy: role of ochratoxins A through biomarkers. Mol Nutr Food Res 50:519-529.
18. Chopra M, Link P, Michels C, Schrenk D. (2010). Characterization of ochratoxin A-induced apoptosis in primary rat hepatocytes. Cell Biol Toxicol 26:239-254.
19. Coronel MB, Marin S, Tarrago M, Cano-Sancho G, Ramos AJ, Sanchis V. (2011). Ochratoxin A and its metabolite ochratoxin alpha in urine and assessment of the exposure of inhabitants of Lleida, Spain. Food Chem Toxicol 49:1436-1442.
20. Creppy EE, Stømer FC, Kern D, Röchenthaler R, Dirheimer G. (1983). Effects of ochratoxin A metabolites on yeast phenylalanyl-tRNA synthetase and on the growth and in vivo protein synthesis of hepatoma cells. Chem Biol Interact 47:239-247.
21. Creppy EE, Castegnaro M, Grosse Y, Méiaux J, Moncharmont P, Waller C et al. (1993). Etude de l'ochratoxicose humaine dans trois réions de France: Alsace, Aquitaine, et réion Rhône - Alpes. In: Creppy EE, Castegnaro M, Dirheimer G, ed. Human ochratoxicosis and its Pathologies. United Kingdom: Colloque INSERM/John Libbey Eurotext, London, 231:147-158.
22. Degen GH, Mayer S, Blaszkewicz M. (2007). Biomonitoring of ochratoxin A in grain workers. Mycotoxin Res 23:88-93.
23. Dinis AM, Lino CM, Pena AS. (2007). Ochratoxin A in nephropathic patients from two cities of central zone in Portugal. J Pharm Biomed Anal 44:553-557.
24. Domijan AM, Peraica M, Fuchs R, Lucic A, Radic B, Balija M, Bosanac I, Grgicevic D. (1999). Ochratoxin A in blood of healthy population in Zagreb. Arh Hig Rada Toksikol 50:263-271.
25. Duarte S, Bento J, Pena A, Lino CM, Delerue-Matos C, Oliva-Teles T, Morais S, Correia M, Oliveira MB, Alves MR, Pereira JA. (2010). Monitoring of ochratoxin A exposure of the Portuguese population through a nationwide urine survey-Winter 2007. Sci Total Environ 408:1195-1198.
26. Duarte SC, Pena A, Lino CM. (2011). Human ochratoxin a biomarkers-from exposure to effect. Crit Rev Toxicol 41:187-212.
27. Dostal A, Cajdova J, Jakusova L, Hudeckova H. (2007). First results of the pilot study of OTA in breast milk in Slovakia. Pediatria 2:319-321 (in Slovak).\
28. EFSA. (2006). Opinion of the scientific panel on contaminants in the food chain on request from the commission related to ochratoxin A in food. EFSA J 365:1-56.
29. El-Sayed AM, Soher EA, Neamat-Allah AA. (2002). Human exposure to mycotoxins in Egypt. Mycotoxin Research 18:23-30.
30. Erkekoglu P, Sabuncuoglu S, Aydin S, Sahin G, Giray B. (2010). Determination of seasonal variations in serum ochratoxin A levels in healthy population living in some regions of Turkey by enzymelinked immunosorbent assay. Toxicon 55:507-513.
31. European Union. (2002). Assessment of dietary intake of ochratoxin A by the population of EU member states. Report of experts participating in Task 3.2.7 Reports on Tasks for Scientific Cooperation. Available at: http://ec.europa.eu/food/fs/scoop/index-en.html. Accessed on 15 July 2009.
32. Filali A, Betbeder AM, Baudrimont I, Benayad A, Soulaymani R, Creppy EE. (2002). Ochratoxin A in human plasma in Morocco: A preliminary survey. Hum Exp Toxicol 21:241-245.
33. Fournier E. (1993). Toxicologie. Nephrotoxines. Paris: Ellipses, 473-485.
34. Frisvad JC, Frank JM, Houbraken JAMP, Kuijpers AFA, Samson RA. (2004). New ochratoxin A producing species of Aspergillus section Circumdati. Studies in Mycology 50:23-43.
35. Fuchs R, Radic B, Ceovic S, Sostaric B, Hult K. (1991). Human exposure to ochratoxin A. IARC Sci Publ., No. 115:131-134.
36. Fukal L, Reisnerova H. (1990). Monitoring of aflatoxins and ochratoxin A in Czechoslovak human sera by immunoassay. Bull Environ Contam Toxicol 44:345-349.
37. Gareis M, Mätlbauer E, Bauer J, Gedek B. (1988). [Determination of ochratoxin A in human milk]. Z Lebensm Unters Forsch 186:114-117.
38. Gareis, Rosner H, Ehrhardt S (2000). Blood serum levels of ochratoxin A and nutrition habits. Arch Lebensmittelhyg 51:108-110.
39. Gilbert J, Brereton P, MacDonald S. (2001). Assessment of dietary exposure to ochratoxin A in the UK using a duplicate diet approach and analysis of urine and plasma samples. Food Addit Contam 18:1088-1093.
40. Golinski P, Grabatkiewicz-Szczenasna J, Chelkowski J, Hult K, Kostecki M. (1991). Possible sources of ochratoxin A in human blood. In: Castegnaro M, Plestina R, Dirheimer G, Chernozemsky IN, Bartsch H, ed. Mycotoxins, Endemic Nephropathy and Urinary Tract Tumours. IARC Scientific Publications. Lyon, France:IARC, 115:153-157.
41. Grajewski J, Jarzemski P, Twaruzek M, Kuzminska K, Trepala M. (2007). The level of ochratoxin A in patients after nephrectomy. Mycotoxin Res 23:22-26.
42. Grosse Y, Monje MC, Mace K, Pfeifer A, Pfohl-Leszkowicz A. (1997). Use of bronchial epithelial cells expressing human cytochrome P450 for study on metabolism and genotoxicity of ochratoxin A. Toxicol in Vitro 10:93-102.
43. Grosso F, Saíd S, Mabrouk I, Fremy JM, Castegnaro M, Jemmali M, Dragacci S. (2003). New data on the occurrence of ochratoxin A in human sera from patients affected or not by renal diseases in Tunisia. Food Chem Toxicol 41:1133-1140.
44. Ǵbay A, Girgin G, Sabuncuoglu SA, Sahin G, Yurdakok M, Yigit S, Tekinalp G. (2009). Ochratoxin A: is it present in breast milk samples obtained from mothers from Ankara, Turkey. Toxicol Lett 189:232-236.
45. Guzmán EM, Guerrero FA, Chaves JA. (2007). [Ocratoxin A in human plasma and coffee from Costa Rica by ELISA]. Arch Latinoam Nutr 57:168-172.
46. Hadlok RM, Wagner G. (1993). Vorkommen von ochratoxin A beim menschen in Deutschland. Fleischwirtsch 73:1079-1080.
47. Hagelberg S, Hult K, Fuchs R. (1989). Toxicokinetics of ochratoxin A in several species and its plasma-binding properties. J Appl Toxicol 9:91-96.
48. Hald B. (1991). Ochratoxin A in human blood in European countries. In Castegnaro M, Plestina R, Dirheimer G, Chernozemsky IN, Bartsch H (ed): Mycotoxins, endemic nephropathy and urinary tract tumours. IARC Scientific Publications, Lyon, France: IARC, 115:159-164.
49. Halliwell B. (1991). Reactive oxygen species in living systems: source, biochemistry and role in human disease. Am J Med 91 (suppl 3C), 14-22.
50. Hassan AM, Sheashaa HA, Fattah MF, Ibrahim AZ, Gaber OA, Sobh MA. (2006). Study of ochratoxin A as an environmental risk that causes renal injury in breast-fed Egyptian infants. Pediatr Nephrol 21:102-105.
51. Hassen W, Abid S, Achour A, Creppy E, Bacha H. (2004). Ochratoxin A and beta2-microglobulinuria in healthy individuals and in chronic interstitial nephropathy patients in the centre of Tunisia: A hot spot of Ochratoxin A exposure. Toxicology 199:185-193.
52. Haubeck HD, Lorkowski G, Kölsch E, Röchenthaler R. (1981). Immunosuppression by ochratoxin A and its prevention by phenylalanine. Appl Environ Microbiol 41:1040-1042.
53. Hmaissia Khlifa K, Ghali R, Mezigh C, Aouni Z, Ghorbel H, Harrzallah K, Machgoul S, Hedhili A. (2008). Serum levels of ochratoxin A in healthy subjects and in nephropathic patients in Tunisia. Ann Biol Clin (Paris) 66:631-636.
54. Hult K, Plestina R, Habazin-Novak V, Radic B, Ceovic S. (1982). Ochratoxin A in human blood and Balkan endemic nephropathy. Arch Toxicol 51:313-321.
55. IARC. (1993). Monographs on the evaluation of carcinogenic risks to humans: Some naturally occuring substances: Food items and costituents, heterocyclic aromatic amines and mycotoxins. Lyon, France: IARC, 56:489-524.
56. Jimenez AM, de Cerain AL, Gonzales-Penas E, Bello J, Betbeder AM, Creppy EE. (1998). Exposure to ochratoxin A in Europe: Comparison with a region of nothern Spain. J Toxicol Toxin Reviews 17:479-491.
57. Jonsyn FE, Maxwell SM, Hendrickse RG. (1995). Ochratoxin A and aflatoxins in breast milk samples from Sierra Leone. Mycopathologia 131:121-126.
58. Jonsyn FE. (1999). Intake of aflatoxins and ochratoxins by infants in Sierra Leone: Possible effects on the general health of these children. J Nutr Environ Med 9:15-22.
59. Jonsyn-Ellis FE. (2000). Seasonal variation in exposure frequency and concentration levels of aflatoxins and ochratoxins in urine samples of boys and girls. Mycopathologia 152:35-40.
60. Jøgensen K. (2005). Occurrence of ochratoxin A in commodities and processed food-a review of EU occurrence data. Food Addit Contam 22 Suppl 1:26-30.
61. Karima HK, Ridha G, Zied A, Chekib M, Salem M, Abderrazek H. (2010). Estimation of Ochratoxin A in human blood of healthy Tunisian population. Exp Toxicol Pathol 62:539-542.
62. Kanisawa M, Suzuki S. (1978). Induction of renal and hepatic tumors in mice by ochratoxin A, a mycotoxin. Gann 69:599-600.
63. Khalef A, Zidane C, Charef A, Gharbi A, tadjerouna M, Betbeder AM, Creppy EE. (1993). Ochratoxicoses humaines en Algéie. In: Creppy E, Castegnaro M, Dirheimer G, ed. Human ochratoxicosis and its pathologies. Paris:John Libbey Eurotext. 231:123-127.
64. Konrad I, Röchenthaler R. (1977). Inhibition of phenylalanine tRNA synthetase from Bacillus subtilis by ochratoxin A. FEBS Lett 83:341-347.
65. Krogh P, Gyrd-Hansen N, Hald B, Larsen S, Nielsen JP, Smith M, Ivanoff C, Meisner H. (1988). Renal enzyme activities in experimental ochratoxin A-induced porcine nephropathy: diagnostic potential of phosphoenolpyruvate carboxykinase and gamma-glutamyl transpeptidase activity. J Toxicol Environ Health 23:1-14.
66. Krogh P. (1992). Role of ochratoxin in disease causation. Food Chem Toxicol 30:213-224.
67. Kuiper-Goodman T, Ominski K, Marquardt RR, Malcom S, McMullen E, Lombaert GA, Morton T. (1993). Estimating human exposure to ochratoxin A in Canada. In: Creppy EE, Castegnaro M, Dirheimer G, ed. Human ochratoxicosis and its pathologies. INSERM/John Libbey Eurotext, Montrouge, France, 167-174.
68. Kuiper-Goodman T, Hilts C, Billiard SM, Kiparissis Y, Richard ID, Hayward S. (2010). Health risk assessment of ochratoxin A for all age-sex strata in a market economy. Food Addit Contam Part A Chem Anal Control Expo Risk Assess 27:212-240.
69. Larsen JC. (1995). Levels of pollutants and their metabolites: exposures to organic substances. Toxicology 101:11-27.
70. Larsen TO, Svendsen A, Smedsgaard J. (2001). Biochemical characterization of ochratoxin A-producing strains of the genus Penicillium. Appl Environ Microbiol 67:3630-3635.
71. Li S, Marquardt RR, Frohlich AA. (2000). Identification of ochratoxins and some of their metabolites in bile and urine of rats. Food Chem Toxicol 38:141-152.
72. Maaroufi K, Achour A, Hammami M, el May M, Betbeder AM, Ellouz F, Creppy EE, Bacha H. (1995). Ochratoxin A in human blood in relation to nephropathy in Tunisia. Hum Exp Toxicol 14:609-614.
73. Maaroufi K, Achour A, Betbeder AM, Hammami M, Ellouz F, Creppy EE, Bacha H. (1995). Foodstuffs and human blood contamination by the mycotoxin ochratoxin A: correlation with chronic interstitial nephropathy in Tunisia. Arch Toxicol 69:552-558.
74. Mac Donald SJ, Langton S, Brereton PA. (2001). Assessment of human oxposure to ochratoxin A in the UK- Relationship between dietary intake and plasma and urine. In: de Koe WJ, Samson RA, van Egmond HP, Gilbert J, Sabino M, ed. Mycotoxins and phycotoxins in perspective at the turn of the millenium. Wageningen: WJ de Koe, 181-188.
75. Malir F, Cerna M, Severa J, Jergeova Z. (1998a). Ochratoxin A -toxicological importance, exposure of humans and health risk. Hygiena 43:49-62. (in Czech)\
76. Malir F, Brndiar M, Roubal T, Severa J, Fixa P, Kacerovsky J, Zahradnik J, Osterreicher J, Knizek J, Cerna M. (2001a). A Study of the Accumulation of Ochratoxin A in Patients with Chronic Renal Insufficiency (CHRI) in the Czech Republic. Mycotoxin Res 17:39-44.
77. Malir F, Roubal T, Brndiar M, Osterreicher J, Severa J, Knizek J, Kacerovsky J, Tmejova M, Betbeder AM, Baudrimont I, Crepppy EE. (2001b). Ochratoxin A in the Czech Republic. J Toxico.-Toxin Reviews 20:261-274.
78. Malir F, Severa J, Roubal T, Kacerovsky J, Fixa P, Moucka P, Zahradnik J, Knizek J, Osterreicher J, Brndiar M, Cerna M. (2001c). The Dialysis of ochratoxin A (OTA). Mycotoxin Res 17A:129-131.
79. Malir F, Ostry V. (Eds.) (2003). Moulds, mycotoxins and public health. NCONZO, Brno. (In Czech). Malir F, Ostry V, Grosse Y, Roubal T, Skarkova J, Ruprich J. (2006). Monitoring the mycotoxins in food and their biomarkers in the Czech Republic. Mol Nutr Food Res 50:513-518.
80. Malir F, Roubal T, Brndiar M, Kacerovsky J, Pacovsky J, Moravek P, Melichar B, Malirova E, Cerna M. (2008). The monitoring mycotoxins and their potential impact on human health: ochratoxin A. (in Czech). In: Proceedings of 4. Seminary with International Participation. Mycotoxins 2008. Prague: Crop Research Institute, 27-36.
81. Manderville RA. (2005). A case for the genotoxicity of ochratoxin A by bioactivation and covalent DNA adduction. Chem Res Toxicol 18:1091-1097.
82. Manderville RA, Pfohl-Leszkowicz A. (2008). Bioactivation and DNA adduction as a rationale for ochratoxin A carcinogenesis. World Mycotox J 1:357-367.
83. Manique R, Pena A, Lino CM, Moltó JC, Mañes J. (2008). Ochratoxin A in the morning and afternoon portions of urine from Coimbra and Valencian populations. Toxicon 51:1281-1287.
84. Mätlbauer E, Usleber E, Dietrich R, Schneider E. (2009). Ochratoxin A in human blood serum- retrospective long-term data. Mycotox Res 25:175-186.
85. Mayura K, Reddy RV, Hayes AW, Berndt WO. (1976). Teratogenic and toxic effects of ochratoxin A in rats. Toxicol Appl Pharmacol 37:331-338.
86. Miraglia M, Brera C, Colatosti M. (1996). Application of Biomarkers to Assessment of Risk to Human Health from Exposure to Mycotoxins. Microchem J 54:472-477.
87. Muñoz K, Vega M, Rios G, Muñoz S, Madariaga R. (2006). Preliminary study of Ochratoxin A in human plasma in agricultural zones of Chile and its relation to food consumption. Food Chem Toxicol 44:1884-1889.
88. Muñoz K, Campos V, Blaszkewicz M, Vega M, Alvarez A, Neira J, Degen G. (2010). Exposure of neonates to ochratoxin A: first biomonitoring results in human milk (colostrum) from Chile. Mycotox Res 26:59-67.
89. Ozçelik N, Kosar A, Soysal D. (2001). Ochratoxin A in human serum samples collected in Isparta-Turkey from healthy individuals and individuals suffering from different urinary disorders. Toxicol Lett 121:9-13.
90. Ostry V, Malir F, Roubal T, Skarkova J, Ruprich J, Cerna M, Creppy EE. (2005). Monitoring of mycotoxin biomarkers in the Czech Republic. Mycotoxin Res 21:49-52.
91. Ostry V, Skarkova J, Kavrik R, Ruprich J. (2010a). An occurrence of ochratoxin A and aflatoxin M1 biomarkers in human urine. In: 32th Mycotoxin Workshop. Lyngby, Denmark:Society for Mycotoxin Research, 145.
92. Ostry V, Skarkova J, Malir F, Ruprich J. (2010b). An occurrence of ochratoxin A, a biomarker of dietary exposure, in human biological materials. In: Proceedings of 6. Seminary with International Participation. Mycotoxins 2010. Prague: VSCHT, 32-40.
93. Pacin AM, Ciancio Bovier EV, Motta E, Resnik SL, Villa D, Olsen M. (2008). Survey of Argentinean human plasma for ochratoxin A. Food Addit Contam Part A Chem Anal Control Expo Risk Assess 25:635-641.
94. Palli D, Miraglia M, Saieva C, Masala G, Cava E, Colatosti M, Corsi AM, Russo A, Brera C. (1999). Serum levels of ochratoxin A in healthy adults in Tuscany: correlation with individual characteristics and between repeat measurements. Cancer Epidemiol Biomarkers Prev 8:265-269.
95. Pena A, Seifrtov́M, Lino C, Silveira I, Solich P. (2006). Estimation of ochratoxin A in portuguese population: new data on the occurrence in human urine by high performance liquid chromatography with fluorescence detection. Food Chem Toxicol 44:1449-1454.
96. Peraica M, Domijan AM, Fuchs R, Lucic A, Radic B. (1999). The occurrence of ochratoxin A in blood in general population of Croatia. Toxicol Lett 110:105-112.
97. Peraica M, Domijan AM, Matasin M, Lucic A, Radic B, Delas F, Horvat M, Bosanac I, Balija M, Grgicevic D. (2001). Variations of ochratoxin A concentration in the blood of healthy populations in some Croatian cities. Arch Toxicol 75:410-414.
98. Pérez de Obanos A, López de Cerain A, Jimenez AM, Gonzales-Penas E, Bello J. (2001). Ochratoxin A in human plasma: new data of exposition in Spain. Rev Toxicol 18:19-23.
99. Perrone G, MuĺG, Susca A, Battilani P, Pietri A, Logrieco A. (2006a). Ochratoxin A production and amplified fragment length polymorphism analysis of Aspergillus carbonarius, Aspergillus tubingensis, and Aspergillus niger strains isolated from grapes in Italy. Appl Environ Microbiol 72:680-685.
100. Perrone G, Susca A, Epifani F, Mulè G. (2006b). AFLP characterization of Southern Europe population of Aspergillus Section Nigri from grapes. Int J Food Microbiol 111 Suppl 1:S22-S27.
101. Petkova-Bocharova T, Castegnaro M. (1985). Ochratoxin A contamination of cereals in an area of high incidence of Balkan endemic nephropathy in Bulgaria. Food Addit Contam 2:267-270.
102. Petkova-Bocharova T, Chernozemsky IN, Castegnaro M. (1988). Ochratoxin A in human blood in relation to Balkan endemic nephropathy and urinary system tumours in Bulgaria. Food Addit Contam 5:299-301.
103. Petkova-Bocharova T, Castegnaro M. (1991). Ochratoxin A in human blood in relation to endemic nephropathy and urinary tract tumors in Bulgaria. In: Castegnaro M, Plestina R, Dirheimer G, Chernozemsky IN, Bartsch H, ed. Mycotoxins, endemic nephropathy and urinary tract tumours. IARC Scientific Publications, Lyon: IARC 115:159-164.
104. Petkova-Bocharova T, Castegnaro M, Pfohl-Leszkowicz A, Garren L, Grosso F, Nikolov I, Vrabcheva T, Dragacci S, Chernozemsky IN. (2003). Analysis of ochratoxin A in serum and urine of inhabitants from an area with Balkan endemic nephropathy: A one - month follow up study. Facta Univ Series Med Biol 10:62-68.
105. Pfohl-Leszkowicz A, Vrabcheva T, Petkova-Bocharova T, Garren L, Grosso F, Nikolov I, Dragacci S, Chernozemsky IN, Castegnaro M. (2004). Analysis of ochratoxin a in serum, urine and food consumed by inhabitants from an area with Balkan endemic nephropathy: A one month follow up study. In: Njapau H, Trujillio S, Van Egmond HP, Park DL ed. Mycotoxins and phycotoxins. Proceeding of the XIth International IUPAC Symposium on Mycotoxins and Phycotoxins, May 17-21, 2004, Bethesda, Maryland, USA; Wageningen:Academic Publishers, 217-224.
106. Pfohl-Leszkowicz A, Tozlovanu M, Stepanovic J, Stefanovic V, Manderville R, Castegnaro M. (2006). Comparative genotoxicity of ochratoxin A and aristolochic acid in human kidney cells: Interpretation of ongoing analyses of food, blood, urine and kidney tissue from Serbia. Colleg Antropologic Suppl 30, 1-17.
107. Pfohl-Leszkowicz A, Manderville RA. (2007). Ochratoxin A: An overview on toxicity and carcinogenicity in animals and humans. Mol Nutr Food Res 51:61-99.
108. Pfohl-Leszkowicz A, Tozlovanu M, Manderville R, Peraica M, Castegnaro M, Stefanovic V. (2007). New molecular and field evidences for the implication of mycotoxins but not aristolochic acid in human nephropathy and urinary tract tumor. Mol Nutr Food Res 51:1131-1146.
109. Pfohl-Leszkowicz A. (2009). Ochratoxin A and aristolochic acid involvement in nephropathies and associated urothelial tract tumours. Arh Hig Rada Toksikol 60:465-483.
110. Pfohl-Leszkowicz A, Manderville RA. (2012). An update on direct genotoxicity as a molecular mechanism of ochratoxin a carcinogenicity. Chem Res Toxicol 25:252-262.
111. Rahimtula AD, Chong X. (1991). Alteration in calcium homeostasis as a possible cause of ochratoxin A nephrotoxicity. In: Castegnaro M, Plestina R, Dirheimer G, Chernozemsky IN, Bartsch H, ed. Mycotoxins, endemic nephropathy and urinary tract tumours. IARC Scientific Publications, Lyon: IARC 115:207-214.
112. Report on carcinogens. (2011). Twelfth Edition: 335-337, 2011.
113. Available at: http://ntp.niehs.nih.gov./go/roc 12. Accessed on 14 December 2011
114. Röner H, Rohrmann B, Peiker G. (2000). Ochratoxin A in human serum. Arch Lebensmittelhyg 51:104-107.
115. Ruprich J, Ostrý V. (1993a). Study of human exposure to ochratoxin A and assessment of possible sources. Cent Eur J Public Health 1:46-48.
116. Ruprich J, Ostrý V. (1993b). Health risk assessment of the mycotoxin ochratoxin A to humans: Czech Republic-Brno-1991/92. Cent Eur J Public Health 1:86-93.
117. Samson RA, Houbraken JAMP, Kuijpers AFA, Frank JM, Frisvad JC. (2004). New ochratoxin A or sclerotium producing species in Aspergillus section Nigri. Studies in Mycology 50:45-46.
118. Sangare-Tigori B, Moukha S, Kouadio JH, Dano DS, Betbeder AM, Achour A, Creppy EE. (2006). Ochratoxin A in human blood in Abidjan, Côte d'Ivoire. Toxicon 47:894-900.
119. Schwerdt G, Freudinger R, Silbernagl S, Gekle M. (1999). Ochratoxin A-binding proteins in rat organs and plasma and in different cell lines of the kidney. Toxicology 135:1-10.
120. Scott PM, Kanhere SR, Lau BP, Lewis DA, Hayward S, Ryan JJ, Kuiper-Goodman T. (1998). Survey of Canadian human blood plasma for ochratoxin A. Food Addit Contam 15:555-562.
121. Scott PM. (2005). Biomarkers of human exposure to ochratoxin A. Food Addit Contam 22 Suppl 1:99-107.
122. Skaug MA, Helland I, Solvoll K, Saugstad OD. (2001). Presence of ochratoxin A in human milk in relation to dietary intake. Food Addit Contam 18:321-327.
123. Solti L, Salamon F, Barna-VetŕI, Gyöngyöi A, SzabóE, Wölfling A. (1997). Ochratoxin A content of human sera determined by a sensitive ELISA. J Anal Toxicol 21:44-48.
124. Steyn PS. (1993). Mycotoxins of human health concern. In Creppy EE, Castegnaro M, Dirheimer G. (ed): Human ochratoxicosis and its Pathologies. London, United Kingdom: Colloque INSERM/John Libbey Eurotext, 231:3-31.
125. Stoev SD. (2010). Studies on carcinogenic and toxic effects of ochratoxin A in chicks. Toxins (Basel) 2:649-664.
126. Stojkovic R, Hult K, Gamulin S, Plestina R. (1984). High affinity binding of ochratoxin A to plasma constituents. Biochem Int 9:33-38.
127. Studer-Rohr I, Schlatter J, Dietrich DR. (2000). Kinetic parameters and intraindividual fluctuations of ochratoxin A plasma levels in humans. Arch Toxicol 74:499-510.
128. Tapai K, Teren J, Mesterhazy A. (1997). Ochratoxin A in the sera of blood donors and ill persons. Cereal Res Commun 25:307-308.
129. Thuvander A, Paulsen JE, Axberg K, Johansson N, Vidnes A, Enghardt-Barbieri H, Trygg K, Lund-Larsen K, Jahrl S, Widenfalk A, Bosnes V, Alexander J, Hult K, Olsen M. (2001). Levels of ochratoxin A in blood from Norwegian and Swedish blood donors and their possible correlation with food consumption. Food Chem Toxicol 39:1145-1151.
130. Timbrell JA. (1998). Biomarkers in toxicology. Toxicology 129:1-12.
131. Turconi G, Guarcello M, Livieri C, Comizzoli S, Maccarini L, Castellazzi AM, Pietri A, Piva G, Roggi C. (2004). Evaluation of xenobiotics in human milk and ingestion by the newborn-an epidemiological survey in Lombardy (Northern Italy). Eur J Nutr 43:191-197.
132. Ueno Y, Maki S, Lin J, Furuya M, Sugiura Y, Kawamura O. (1998). A 4-year study of plasma ochratoxin A in a selected population in Tokyo by immunoassay and immunoaffinity column-linked HPLC. Food Chem Toxicol 36:445-449.
133. van der Merwe KJ, Steyn PS, Fourie L, Scott DB, Theron JJ. (1965). Ochratoxin A, a toxic metabolite produced by Aspergillus ochraceus Wilh. Nature 205:1112-1113.
134. Vukelic M, Sostaric B, Belicza M. (1992). Pathomorphology of Balkan endemic nephropathy. Food Chem Toxicol 30:193-200.
135. Wafa EW, Yahya RS, Sobh MA, Eraky I, el-Baz M, el-Gayar HA, Betbeder AM, Creppy EE. (1998). Human ochratoxicosis and nephropathy in Egypt: A preliminary study. Hum Exp Toxicol 17:124-129.
136. Wu Q, Dohnal V, Huang L, Kuca K, Wang X, Chen G, Yuan Z. (2011). Metabolic pathways of ochratoxin A. Curr Drug Metab 12:1-10.
137. Zepnik H, Völkel W, Dekant W. (2003). Toxicokinetics of the mycotoxin ochratoxin A in F 344 rats after oral administration. Toxicol Appl Pharmacol 192:36-44.
138. Zimmerli B, Dick R. (1995). Determination of ochratoxin A at the ppt level in human blood, serum, milk and some foodstuffs by highperformance liquid chromatography with enhanced fluorescence detection and immunoaffinity column cleanup: methodology and Swiss data. J Chromatogr B, Biomed Appl 666:85-99.